title: Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.
abstract: Locus ceruleus (LC) is the main subcortical site of norepinephrine synthesis. In Alzheimer's disease (AD) patients and rodent models, degeneration of LC neurons and reduced levels of norepinephrine in LC projection areas are significantly correlated with the increase in amyloid plaques, neurofibrillary tangles, and severity of dementia. Activated microglia play a pivotal role in the progression of AD by either clearing amyloid beta peptide (Abeta) deposits through uptake of Abeta or releasing cytotoxic substances and proinflammatory cytokines. Here, we investigated the effect of norepinephrine on Abeta uptake and clearance by murine microglia and explored the underlying mechanisms. We found that murine microglia cell line N9 and primary microglia expressed beta(2) adrenergic receptor (AR) but not beta(1) and beta(3)AR. Norepinephrine and isoproterenol upregulated the expression of Abeta receptor mFPR2, a mouse homolog of human formyl peptide receptor FPR2, through activation of beta(2)AR in microglia. Norepinephrine also induced mFPR2 expression in mouse brain. Activation of beta(2)AR in microglia promoted Abeta(42) uptake through upregulation of mFPR2 and enhanced spontaneous cell migration but had no effect on cell migration in response to mFPR2 agonists. Furthermore, activation of beta(2)AR on microglia induced the expression of insulin-degrading enzyme and increased the degradation of Abeta(42). Mechanistic studies showed that isoproterenol induced mFPR2 expression through ERK1/2-NF-kappaB and p38-NF-kappaB signaling pathways. These findings suggest that noradrenergic innervation from LC is needed to maintain adequate Abeta uptake and clearance by microglia, and norepinephrine is a link between neuron and microglia to orchestrate the host response to Abeta in AD.
authors.affiliation: Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Graduate School of the Chinese Academy of Sciences, Shanghai, People's Republic of China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Kong
authors.forename: Lingfei
authors.initials: L
authors.lastname: Ruan
authors.forename: Lihua
authors.initials: L
authors.lastname: Qian
authors.forename: Xiaolei
authors.initials: X
authors.lastname: Liu
authors.forename: Yingying
authors.initials: Y
authors.lastname: Le
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D002460:Cell Line; D002478:Cells, Cultured; D004705:Endocytosis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007339:Insulysin / Q000096:biosynthesis* / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology* / Q000502:physiology; D010446:Peptide Fragments / Q000037:antagonists & inhibitors / Q000378:metabolism*; D044042:Receptors, Formyl Peptide / Q000096:biosynthesis* / Q000502:physiology; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology*
chemical_list: D000318:Adrenergic beta-Agonists; D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D044042:Receptors, Formyl Peptide; C075222:amyloid beta-protein (1-42); C481578:formyl peptide receptor 2, mouse; D007339:Insulysin; D009638:Norepinephrine
references.citation: J Neuroinflammation. 2004 Jun 30;1(1):9
references.pmid: 15285793
references.citation: Am J Pathol. 1998 Jan;152(1):307-17
references.pmid: 9422548
references.citation: Neurobiol Aging. 2007 Aug;28(8):1206-14
references.pmid: 16837104
references.citation: Brain. 2005 Aug;128(Pt 8):1778-89
references.pmid: 15857927
references.citation: Nat Protoc. 2006;1(1):241-5
references.pmid: 17406239
references.citation: Nat Protoc. 2006;1(1):16-22
references.pmid: 17406207
references.citation: Am J Pathol. 2003 Jan;162(1):313-9
references.pmid: 12507914
references.citation: J Neurosci. 2006 Feb 1;26(5):1343-54
references.pmid: 16452658
references.citation: Pharmacol Rev. 2009 Jun;61(2):119-61
references.pmid: 19498085
references.citation: Biochem Soc Trans. 2005 Nov;33(Pt 5):1101-5
references.pmid: 16246055
references.citation: J Biol Chem. 2001 Jun 29;276(26):23645-52
references.pmid: 11316806
references.citation: Neuroscience. 2005;135(4):1295-307
references.pmid: 16165282
references.citation: Brain. 2006 Nov;129(Pt 11):3006-19
references.pmid: 16984903
references.citation: Neurosci Res. 1995 Jul;22(4):399-409
references.pmid: 7478305
references.citation: Nature. 1999 Jul 8;400(6740):173-7
references.pmid: 10408445
references.citation: Trends Neurosci. 2002 Jan;25(1):22-6
references.pmid: 11801334
references.citation: Am J Physiol Lung Cell Mol Physiol. 2000 Oct;279(4):L675-82
references.pmid: 11000127
references.citation: Annu Rev Neurosci. 1999;22:219-40
references.pmid: 10202538
references.citation: J Immunol. 2008 Nov 1;181(9):6503-13
references.pmid: 18941241
references.citation: Nat Med. 2000 Aug;6(8):916-9
references.pmid: 10932230
references.citation: J Biol Chem. 2008 Oct 24;283(43):29028-36
references.pmid: 18678875
references.citation: Curr Alzheimer Res. 2008 Jun;5(3):342-5
references.pmid: 18537547
references.citation: Trends Neurosci. 1996 Aug;19(8):312-8
references.pmid: 8843599
references.citation: Alzheimer Dis Assoc Disord. 1987;1(4):256-62
references.pmid: 3453748
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):6058-63
references.pmid: 20231476
references.citation: J Neuroimmunol. 2006 Feb;171(1-2):135-44
references.pmid: 16303184
references.citation: Science. 1992 Apr 10;256(5054):184-5
references.pmid: 1566067
references.citation: FASEB J. 2005 Dec;19(14):2032-4
references.pmid: 16219804
references.citation: J Neurosci. 2003 Nov 26;23(34):10879-83
references.pmid: 14645482
references.citation: Neurosci Lett. 1986 Mar 14;64(3):247-52
references.pmid: 3960404
references.citation: J Mol Cell Cardiol. 1999 Nov;31(11):2017-30
references.pmid: 10591028
references.citation: J Neurosci. 1998 Mar 15;18(6):2161-73
references.pmid: 9482801
references.citation: J Neurosci. 2008 Aug 13;28(33):8354-60
references.pmid: 18701698
references.citation: J Neurosci Res. 2002 Oct 15;70(2):232-7
references.pmid: 12271472
references.citation: J Biol Chem. 2006 Feb 10;281(6):3651-9
references.pmid: 16339765
references.citation: Neuroscience. 1989;33(3):567-78
references.pmid: 2636710
references.citation: Brain Res Brain Res Rev. 1992 Jan-Apr;17(1):61-74
references.pmid: 1638276
references.citation: J Biol Chem. 1998 Dec 4;273(49):32730-8
references.pmid: 9830016
references.citation: J Immunol. 2007 Feb 1;178(3):1759-66
references.pmid: 17237425
references.citation: Nature. 1999 Jun 24;399(6738 Suppl):A23-31
references.pmid: 10392577
references.citation: Int Immunopharmacol. 2009 Aug;9(9):1126-30
references.pmid: 19426837
references.citation: Immunology. 1993 May;79(1):125-30
references.pmid: 8509133
references.citation: Glia. 2009 Nov 15;57(15):1600-9
references.pmid: 19330844
references.citation: Exp Neurol. 2000 Jan;161(1):127-38
references.pmid: 10683279
references.citation: Brain Pathol. 1998 Jan;8(1):65-72
references.pmid: 9458167
references.citation: Neurobiol Dis. 2002 Aug;10(3):366-77
references.pmid: 12270697
references.citation: Neuron. 1996 Sep;17(3):553-65
references.pmid: 8816718
references.citation: J Neuroimmunol. 2006 Apr;173(1-2):87-95
references.pmid: 16386803
references.citation: J Biol Chem. 2006 Nov 24;281(47):35812-25
references.pmid: 17008315
references.citation: Neuropharmacology. 2002 Nov;43(6):1026-34
references.pmid: 12423672
references.citation: Neuron. 2006 Feb 16;49(4):489-502
references.pmid: 16476660
references.citation: J Biol Chem. 2009 Nov 27;284(48):33400-8
references.pmid: 19679659
references.citation: Mol Cell Neurosci. 2005 May;29(1):128-38
references.pmid: 15866053
references.citation: Nature. 1996 Aug 22;382(6593):685-91
references.pmid: 8751438
references.citation: J Neurosci. 2002 Apr 1;22(7):2434-42
references.pmid: 11923407
references.citation: Neurochem Int. 2010 Nov;57(4):411-20
references.pmid: 20380860
references.citation: J Immunol. 2004 Jun 1;172(11):7078-85
references.pmid: 15153530
references.citation: Ernst Schering Res Found Workshop. 2002;(39):105-32
references.pmid: 12066408
references.citation: Trends Immunol. 2002 Nov;23(11):541-8
references.pmid: 12401407
references.citation: Ann Med. 2001 Nov;33(8):510-5
references.pmid: 11730157
references.citation: Neurobiol Aging. 2007 Mar;28(3):327-35
references.pmid: 16574280
references.citation: Neuron. 2008 Jun 12;58(5):681-93
references.pmid: 18549781
references.citation: J Neurosci. 2003 May 1;23(9):3745-51
references.pmid: 12736345
references.citation: Neuron. 2003 Dec 18;40(6):1087-93
references.pmid: 14687544
references.citation: CNS Neurol Disord Drug Targets. 2007 Dec;6(6):388-97
references.pmid: 18220778
references.citation: J Comp Neurol. 1975 Nov 15;164(2):209-31
references.pmid: 810499
references.citation: Endocrinology. 2008 Feb;149(2):672-80
references.pmid: 17962352
references.citation: Biochem Biophys Res Commun. 2004 Jun 25;319(2):304-11
references.pmid: 15178407
references.citation: J Immunol. 2000 Oct 15;165(8):4598-605
references.pmid: 11035102
references.citation: J Immunol. 2002 Jan 1;168(1):434-42
references.pmid: 11751990
references.citation: J Neurosci. 2001 Jan 15;21(2):RC123
references.pmid: 11160457
references.citation: FASEB J. 2001 Nov;15(13):2454-62
references.pmid: 11689470
references.citation: J Leukoc Biol. 2001 Jul;70(1):155-61
references.pmid: 11435499
references.citation: J Neurosci Res. 2005 Aug 1;81(3):390-6
references.pmid: 15948176
references.citation: Acta Neuropathol. 1992;84(3):225-33
references.pmid: 1414275